Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
4
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
fda
4
×
indiana blog main
indiana top stories
life sciences
messenger rna
4
×
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
bristol-myers squibb
cancer
cancer immunotherapy
clinical trials
investing
biogen
celgene
deals
eli lilly
glaxosmithkline
ipo
What
bio
roundup
companies
crispr
growing
ipo
million
new
therapeutics
alliance
allogene
approved
biotechs
bristol
buy
calls
cancer
changing
club
color
continued
crop
days
digital
disease
diversity
drug
epidemic
exceeded
fatty
fda
firms
frenzied
group
haul
hot
hours
immunotherapy
investors
joined
Language
unset
Current search:
fda
×
biotech
×
" messenger rna "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M
